Obseity | sciencenewsnet.in

Breaking News

Medicated nasal spray will slash opioid-related hospital admissions

Research highlights greater financial hardship and importance of the legal system for divorced survivors of domestic abuse

Are Health Care Disparities Tied to Worse Outcomes for Kids with MS?

For Those with CTE, Family History of Mental Illness Tied to Aggression in Middle Age

What a Second Trump Presidency Will Mean for Energy and Climate

Patient returns to Houston Methodist 20 years after lifesaving surgery

Neurosurgery Joins Medical Societies to Urge Congress to Protect Medicare Patients and Physician Practices Before Year-End

Market Study Sheds Light on How Inclusive Shopping Experiences Make All Consumers Feel Valued

U.S. Department of Labor approves IU to lead K-12 teacher apprenticeship program

NJIT STEM Forum Explores AI, Digital Transformation in Schools

28 Nov, 2024

Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes

February 23, 2023 sarah JonasResearch Results

Researchers recently completed a phase 3 clinical trial that assessed the efficacy and safety of two different classes of oral agents for the treatment of type 2 diabetes in young people aged 10-17 years.